Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VGX-410 (Mifepristone) in HCV Infection
NCT00255177Phase 2Completed
- Sponsor
- VGX Pharmaceuticals
- Start
- Nov 2005
- Primary completion
- Sep 2007
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mifepristone in hepatitis C virus infection, sponsored by VGX Pharmaceuticals. Started Nov 2005; status: completed.
02
Drugs
mifepristone
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00255177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00255177.